Healthcare Realty Trust (HR) Projected to Release Earnings on Thursday

Key Points

• Healthcare Realty Trust is expected to report Q3 2026 results on October 29 after market close, with analysts forecasting $0.0078 in EPS and $275.43 million in revenue. The company’s FY 2026 EPS guidance is $1.620–$1.660.
• The REIT’s prior quarter missed earnings expectations, reporting a $0.13 loss per share despite revenue exceeding estimates; revenue declined 5.3% year over year.
• Shares opened at $17.21, near the company’s 52-week low, while the stock offers a 5.6% dividend yield. Analysts maintain a consensus “Hold” rating with a $21.36 target price.

Healthcare Realty Trust (NYSE:HR - Get Free Report) is projected to post its Q3 2026 results after the market closes on Thursday, October 29th. Analysts expect the company to announce earnings of $0.0078 per share and revenue of $275.43 million for the quarter. Healthcare Realty Trust has set its FY 2026 guidance at 1.620-1.660 EPS. Investors may review the information on the company's upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Friday, October 30, 2026 at 9:00 AM ET.

Healthcare Realty Trust (NYSE:HR - Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The real estate investment trust reported ($0.13) earnings per share for the quarter, missing analysts' consensus estimates of $0.40 by ($0.53). Healthcare Realty Trust had a negative return on equity of 1.91% and a negative net margin of 7.59%. The company had revenue of $278.58 million for the quarter, compared to analysts' expectations of $271.60 million. During the same period in the prior year, the company posted $0.41 EPS. The firm's revenue was down 5.3% compared to the same quarter last year. On average, analysts expect Healthcare Realty Trust to post $1.65 EPS for the current fiscal year and $1.73 EPS for the next fiscal year.

Healthcare Realty Trust Price Performance

Shares of NYSE HR opened at $17.21 on Thursday. The stock's 50-day moving average is $18.35 and its two-hundred day moving average is $19.36. Healthcare Realty Trust has a 1-year low of $16.31 and a 1-year high of $22.04. The company has a market cap of $5.90 billion, a price-to-earnings ratio of -66.21 and a beta of 0.97.

Healthcare Realty Trust Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, August 26th. Shareholders of record on Tuesday, August 11th were given a $0.24 dividend. The ex-dividend date of this dividend was Tuesday, August 11th. This represents a $0.96 dividend on an annualized basis and a dividend yield of 5.6%. Healthcare Realty Trust's dividend payout ratio is currently -369.23%.

Insider Buying and Selling

In other Healthcare Realty Trust news, COO Robert Hull sold 21,000 shares of the company's stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $19.11, for a total value of $401,310.00. Following the transaction, the chief operating officer directly owned 276,338 shares in the company, valued at approximately $5,280,819.18. This represents a 7.06% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.56% of the company's stock.

Analyst Ratings Changes

Several equities analysts recently commented on the company. Wells Fargo & Company dropped their target price on Healthcare Realty Trust from $20.00 to $18.00 and set an "equal weight" rating on the stock in a report on Monday. Royal Bank Of Canada lifted their target price on shares of Healthcare Realty Trust from $21.00 to $22.00 and gave the company a "sector perform" rating in a report on Friday, August 7th. UBS Group reduced their price objective on Healthcare Realty Trust from $21.00 to $18.00 and set a "neutral" rating for the company in a research note on Tuesday, October 13th. Cantor Fitzgerald raised their target price on shares of Healthcare Realty Trust from $22.00 to $24.00 and gave the stock an "overweight" rating in a research note on Friday, July 31st. Finally, JPMorgan Chase & Co. raised their price target on Healthcare Realty Trust from $19.00 to $21.00 and gave the company a "neutral" rating in a report on Thursday, July 9th. Five analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $21.36.

About Healthcare Realty Trust

Healthcare Realty Trust Incorporated NYSE: HR is a real estate investment trust focused on owning, managing, acquiring and developing outpatient healthcare properties. Its portfolio primarily includes medical office buildings, ambulatory surgery centers, outpatient facilities and other properties used by healthcare providers.

The company leases space to health systems, physician groups and other healthcare organizations, with properties generally located on or near hospital campuses and in growing outpatient care settings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.